Skip to main content

Spyre Therapeutics, Inc.

SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001636282

In the last 90 days, Spyre Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 265 institutions reported holding it in 13F filings for Q2 2026, worth $8.52B in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Spyre Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
198
+47 vs. Q4 2025
Shares held
82.7M
+5.74M (+7.5%) vs. Q4 2025
Total value
$4.16B
+$1.64B (+65.2%) vs. Q4 2025
New holders
58
67 more added
Sold out
11
49 more reduced

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 198 institutions
Q1 2021: 84 institutionsQ2 2021: 78 institutionsQ3 2021: 77 institutionsQ4 2021: 86 institutionsQ1 2022: 84 institutionsQ2 2022: 67 institutionsQ3 2022: 55 institutionsQ4 2022: 51 institutionsQ1 2023: 45 institutionsQ2 2023: 44 institutionsQ3 2023: 29 institutionsQ4 2023: 54 institutionsQ1 2024: 103 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 129 institutionsQ2 2025: 129 institutionsQ3 2025: 137 institutionsQ4 2025: 153 institutionsQ1 2026: 198 institutionsQ2 2026: 265 institutions
Value heldQ1 2026: $4.16B
Q1 2021: $328.7MQ2 2021: $285.8MQ3 2021: $322.5MQ4 2021: $189.4MQ1 2022: $95.4MQ2 2022: $24.8MQ3 2022: $23.5MQ4 2022: $19.2MQ1 2023: $12.0MQ2 2023: $31.9MQ3 2023: $43.9MQ4 2023: $601.0MQ1 2024: $1.21BQ2 2024: $1.18BQ3 2024: $1.51BQ4 2024: $1.39BQ1 2025: $1.00BQ2 2025: $952.6MQ3 2025: $1.08BQ4 2025: $2.65BQ1 2026: $4.16BQ2 2026: $8.52B
Institutions holding SYRE and their total value by quarter
QuarterHoldersValue
Q2 2026265$8.52B
Q1 2026198$4.16B
Q4 2025153$2.65B
Q3 2025137$1.08B
Q2 2025129$952.6M
Q1 2025129$1.00B
Q4 2024131$1.39B
Q3 2024119$1.51B
Q2 2024107$1.18B
Q1 2024103$1.21B
Q4 202354$601.0M
Q3 202329$43.9M
Q2 202344$31.9M
Q1 202345$12.0M
Q4 202251$19.2M
Q3 202255$23.5M
Q2 202267$24.8M
Q1 202284$95.4M
Q4 202186$189.4M
Q3 202177$322.5M
Q2 202178$285.8M
Q1 202184$328.7M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Spyre Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding SYRE in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Warren Averett Asset Management, LLC25,966$1.31M0.01%+120.0%Added
Profund Advisors LLC26,043$1.31M0.05%+5,450+26.5%Added
State of Wisconsin Investment Board26,523$1.34M0.00%−729−2.7%Reduced
Cinctive Capital Management LP27,430$1.38M0.09%−8,505−23.7%Reduced
Virginia Retirement Systems Et Al27,550$1.39M0.01%+2,600+10.4%Added
Susquehanna International Group, LLP28,962$1.46M0.00%+22,851+373.9%Added
Vanguard Global Advisers, LLC31,141$1.57M0.00%+31,141New
Wells Fargo & Company33,208$1.68M0.00%−49,208−59.7%Reduced
Vanguard Asset Management, Ltd33,232$1.68M0.00%+33,232New
Mirae Asset Global ETFs Holdings Ltd.36,323$1.81M0.00%+1,179+3.4%Added
MetLife Investment Management38,407$1.94M0.01%+396+1.0%Added
Legal & General Group Plc44,792$2.26M0.00%−11,656−20.6%Reduced
Barclays PLC45,786$2.31M0.00%−136,738−74.9%Reduced
Alliancebernstein L.P.70,900$2.32M0.00%+3,400+5.0%Added
Dimensional Fund Advisors LP47,697$2.41M0.00%−29,593−38.3%Reduced
Susquehanna Portfolio Strategies, LLC53,101$2.68M0.04%00.0%Unchanged
Voya Investment Management LLC53,970$2.72M0.00%+26,693+97.9%Added
Balyasny Asset Management LLC55,477$2.80M0.01%−17,988−24.5%Reduced
Rafferty Asset Management, LLC56,920$2.87M0.01%+3,510+6.6%Added
Schroder Investment Management Group63,684$2.89M0.00%+2,110+3.4%Added
California State Teachers Retirement System59,242$2.99M0.00%+11,204+23.3%Added
Fred Alger Management, LLC59,453$3.00M0.01%+59,453New
Prudential Financial Inc59,555$3.00M0.00%+59,555New
Alps Advisors Inc63,939$3.23M0.02%+231+0.4%Added
Rockefeller Capital Management L.P.64,002$3.23M0.01%+63,453+11,557.9%Added
HealthInvest Partners AB62,735$3.49M1.13%+62,735New
Mercer Global Advisors Inc71,091$3.59M0.01%−35,225−33.1%Reduced
Rhumbline Advisers85,121$4.29M0.00%+2,165+2.6%Added
ExodusPoint Capital Management, LP87,065$4.39M0.04%+49,194+129.9%Added
Swiss National Bank96,500$4.87M0.00%00.0%Unchanged
F/M Investments LLC99,460$5.02M0.33%−4,258−4.1%Reduced
Seven Grand Managers, LLC100,000$5.04M0.34%00.0%Unchanged
B Group, Inc.100,000$5.04M3.74%00.0%Unchanged
Citadel Advisors LLC108,135$5.45M0.00%+44,231+69.2%Added
Manufacturers Life Insurance Company, The112,841$5.69M0.00%−16,172−12.5%Reduced
Armistice Capital, LLC120,931$6.10M0.20%−75,495−38.4%Reduced
Deutsche Bank AG129,242$6.52M0.00%+7,301+6.0%Added
Invesco Ltd.132,390$6.68M0.00%−18,544−12.3%Reduced
TD Asset Management Inc137,390$6.93M0.01%−12,432−8.3%Reduced
Marshall Wace, LLP139,259$7.02M0.01%+139,259New
HighVista Strategies LLC146,264$7.38M2.04%−41,942−22.3%Reduced
Millennium Management LLC146,639$7.40M0.01%+70,445+92.5%Added
Ensign Peak Advisors, Inc148,537$7.49M0.01%+148,537New
Nuveen, LLC153,899$7.76M0.00%+2,919+1.9%Added
Ameriprise Financial Inc159,217$8.03M0.00%+120,961+316.2%Added
StemPoint Capital LP167,606$8.45M1.62%+135,229+417.7%Added
Universal- Beteiligungs- und Servicegesellschaft mbH170,381$8.59M0.01%−830−0.5%Reduced
First Trust Advisors LP178,389$9.00M0.01%+178,389New
Silverarc Capital Management, LLC186,618$9.41M1.11%−1,119−0.6%Reduced
Bank of New York Mellon Corp191,395$9.65M0.00%−1,435−0.7%Reduced
Boothbay Fund Management, LLC193,031$9.74M0.23%+193,031New
UBS Asset Management Americas Inc207,314$10.5M0.00%+145,098+233.2%Added
Morgan Stanley246,719$12.4M0.00%+63,985+35.0%Added
Woodline Partners LP265,892$13.4M0.05%00.0%Unchanged
Goldman Sachs Group Inc269,938$13.6M0.00%−5,127−1.9%Reduced
Victory Capital Management Inc292,126$14.7M0.01%+146,047+100.0%Added
Blackstone Group Inc.292,847$14.8M0.06%−208,151−41.5%Reduced
ADAR1 Capital Management, LLC338,323$17.1M1.03%+304,272+893.6%Added
Samlyn Capital, LLC396,661$20.0M0.34%+396,661New
Emerald Mutual Fund Advisers Trust408,113$20.6M1.00%−4,258−1.0%Reduced
Vanguard Fiduciary Trust Co464,651$23.4M0.01%+464,651New
Pictet Asset Management Holding SA491,649$24.8M0.03%−422,311−46.2%Reduced
Charles Schwab Investment Management Inc562,653$28.4M0.00%−11,969−2.1%Reduced
Northern Trust Corp578,907$29.2M0.00%+17,884+3.2%Added
Vanguard Portfolio Management LLC585,130$29.5M0.00%+585,130New
Candriam Luxembourg S.C.A.610,282$30.8M0.16%+184,748+43.4%Added
Emerald Advisers, LLC613,365$30.9M0.98%−22,744−3.6%Reduced
Capital World Investors666,564$33.6M0.00%+466,392+233.0%Added
UBS Group AG671,235$33.9M0.01%−9,331−1.4%Reduced
Polar Capital Holdings Plc792,847$40.0M0.17%+52,521+7.1%Added
Siren, L.L.C.818,598$41.3M1.14%00.0%Unchanged
Caligan Partners LP878,127$44.3M3.13%+878,127New
JPMorgan Chase & Co979,299$44.5M0.00%+916,348+1,455.7%Added
Franklin Resources Inc882,833$44.5M0.01%−226,441−20.4%Reduced
Braidwell LP932,823$47.1M1.57%−701,792−42.9%Reduced
Baker Bros. Advisors LP1,000,000$50.4M0.29%00.0%Unchanged
Bank of America Corp1,228,093$61.9M0.00%+808,366+192.6%Added
Affinity Asset Advisors, LLC1,279,134$64.5M3.78%−153,457−10.7%Reduced
Remedium Capital Partners, LLC1,456,231$73.5M26.13%00.0%Unchanged
Price T Rowe Associates Inc1,598,730$80.6M0.01%−3,152−0.2%Reduced
Ra Capital Management, L.P.1,621,620$81.8M0.87%00.0%Unchanged
Janus Henderson Group PLC1,656,164$83.6M0.04%−172,845−9.5%Reduced
Geode Capital Management, LLC1,720,912$86.8M0.01%+61,772+3.7%Added
Capital International Investors1,746,129$88.1M0.02%−1,746,412−50.0%Reduced
Wellington Management Group LLP1,824,811$92.0M0.02%+275,527+17.8%Added
Tang Capital Management LLC1,892,200$95.4M4.85%00.0%Unchanged
TCG Crossover Management, LLC1,900,582$95.9M2.74%00.0%Unchanged
Commodore Capital LP1,912,380$96.5M5.58%−475,865−19.9%Reduced
Paradigm Biocapital Advisors LP1,957,266$98.7M2.02%+490,000+33.4%Added
State Street Corp2,607,031$131.5M0.00%+344,192+15.2%Added
Driehaus Capital Management LLC2,790,785$140.8M1.03%−91,635−3.2%Reduced
Vanguard Capital Management LLC3,057,401$154.2M0.00%+3,057,401New
VR Adviser, LLC3,685,448$185.9M6.94%00.0%Unchanged
Perceptive Advisors LLC3,783,225$190.8M3.77%+714,000+23.3%Added
Fairmount Funds Management LLC4,018,101$202.7M14.64%00.0%Unchanged
RTW Investments, LP4,171,996$210.4M2.09%00.0%Unchanged
BlackRock, Inc.5,521,221$278.5M0.00%−8800.0%Reduced
FMR LLC11,781,024$594.2M0.03%+142,205+1.2%Added
Deerfield Management Company, L.P. (Series C)0$00.00%−710,626−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−662,351−100.0%Sold out